| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.32 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |